Ibuprofen pharmacology
Pro Research Analysisby 
Searched over 200M research papers for "ibuprofen pharmacology"
Ibuprofen Mechanism of Action and Pharmacological Properties
Ibuprofen is a widely used nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), which are responsible for the production of prostanoids involved in pain, inflammation, and fever. This inhibition leads to its analgesic, anti-inflammatory, and antipyretic effects, making it effective for treating a range of conditions such as musculoskeletal pain, arthritis, and fever in both adults and children Rainsford2009Upadhyay2021Mazaleuskaya2015.
Dosage, Therapeutic Uses, and Efficacy
At low over-the-counter (OTC) doses (800–1,200 mg/day), ibuprofen is effective for minor pain, inflammation, and fever, with a safety profile similar to paracetamol. Higher prescription doses (1,800–2,400 mg/day) are used for chronic conditions like rheumatoid arthritis and osteoarthritis Rainsford2009Mazaleuskaya2015. In pediatric patients, ibuprofen is commonly used for acute pain and fever, and is often more effective than paracetamol for reducing fever Rainsford2009Mazaleuskaya2015Barbagallo2018. It is also used off-label for promoting closure of patent ductus arteriosus in preterm infants .
Pharmacokinetics and Metabolism
Ibuprofen is rapidly absorbed after oral administration, with a short plasma half-life of elimination. It is typically administered as a racemic mixture, but only the S-enantiomer (dexibuprofen) is pharmacologically active. The drug undergoes stereoselective metabolism and chiral inversion, with protein binding and metabolic pathways influenced by genetic factors and potential drug interactions Rainsford2009Hao2005Huang2023. Sustained-release formulations and transdermal preparations have shown similar safety and bioequivalence profiles in healthy volunteers Huang2023Xie2021.
Safety Profile and Adverse Effects
Ibuprofen is considered one of the safest conventional NSAIDs, especially at OTC doses, with a low risk of serious gastrointestinal (GI), cardiovascular (CV), hepatic, and renal adverse events compared to other NSAIDs and coxibs Rainsford2009Bushra2010Singh2022+1 MORE. GI toxicity is the most common side effect, but is generally mild and less frequent than with other NSAIDs. Renal effects are minimal, though dehydration can increase the risk of kidney damage, particularly in children Rainsford2009Barbagallo2018. Some studies have reported a slightly higher risk of CV events, but overall risks are lower than with certain other NSAIDs . Ibuprofen does not cause the irreversible liver damage seen with paracetamol .
Drug Interactions and Special Considerations
Ibuprofen may interfere with the anti-platelet effects of aspirin, so caution is advised in patients taking aspirin for cardiovascular protection . Drug-drug and food-drug interactions are possible, and genetic differences can affect metabolism and response Bushra2010Singh2022Hao2005. In the context of COVID-19, current evidence does not support concerns that ibuprofen increases infection risk or worsens outcomes, and there is no evidence of direct interaction with the SARS-CoV-2 virus or its receptor ACE2 .
Emerging Therapeutic Roles
Beyond its established uses, ibuprofen has shown potential anti-tumorigenic and neuroprotective effects in experimental studies, suggesting possible future applications in cancer and neurodegenerative diseases. However, long-term or excessive use can increase the risk of organ damage, and further research is needed to minimize these risks while exploring new therapeutic avenues .
Conclusion
Ibuprofen is a well-established NSAID with proven efficacy for pain, inflammation, and fever, and a favorable safety profile at recommended doses. Its pharmacological actions are primarily due to COX inhibition, and it is suitable for both adults and children. While generally safe, attention to dosing, hydration status, and potential drug interactions is important to minimize adverse effects. Ongoing research continues to explore new therapeutic uses and strategies to further improve its safety and effectiveness Rainsford2009Bushra2010Upadhyay2021+7 MORE.
Sources and full results
Most relevant research papers on this topic